Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Related Articles by Review for PubMed (Select 16325604)

1.

Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.

Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G.

Am J Obstet Gynecol. 2005 Dec;193(6):2004-9.

PMID:
16325604
2.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
3.

Maternal and neonatal outcomes of elective induction of labor.

Caughey AB, Sundaram V, Kaimal AJ, Cheng YW, Gienger A, Little SE, Lee JF, Wong L, Shaffer BL, Tran SH, Padula A, McDonald KM, Long EF, Owens DK, Bravata DM.

Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Review.

4.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
5.

Accidental electric shock in pregnancy: a prospective cohort study.

Einarson A, Bailey B, Inocencion G, Ormond K, Koren G.

Am J Obstet Gynecol. 1997 Mar;176(3):678-81. Review.

PMID:
9077628
6.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
7.

Obstetrical complications associated with abnormal maternal serum markers analytes.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P; Society of Obstetricians and Gynaecologists of Canada Genetics Committee.

J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. Review. English, French.

PMID:
19038077
8.
9.

The use of selective serotonin reuptake inhibitors in pregnancy.

Wen SW, Walker M.

J Obstet Gynaecol Can. 2004 Sep;26(9):819-22. Review.

PMID:
15361279
10.

[The safety profile of escitalopram in pregnancy and breastfeeding].

Bellantuono C, Orsolini L, Bozzi F.

Riv Psichiatr. 2013 Nov-Dec;48(6):407-14. doi: 10.1708/1379.15335. Review. Italian.

PMID:
24441517
11.
13.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258
14.

DDAVP use during pregnancy: an analysis of its safety for mother and child.

Ray JG.

Obstet Gynecol Surv. 1998 Jul;53(7):450-5. Review.

PMID:
9662731
15.

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects.

Hallberg P, Sjöblom V.

J Clin Psychopharmacol. 2005 Feb;25(1):59-73. Review.

PMID:
15643101
16.
17.

The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.

Bellantuono C, Bozzi F, Orsolini L, Catena-Dell'Osso M.

Hum Psychopharmacol. 2012 Nov;27(6):534-9. doi: 10.1002/hup.2265. Epub 2012 Oct 9. Review.

PMID:
23044635
18.

Fetal and neonatal effects of cytotoxic agents.

Barber HR.

Obstet Gynecol. 1981 Nov;58(5 Suppl):41S-7S. Review.

PMID:
7031541
19.

How do SSRIs help patients with irritable bowel syndrome?

Creed F.

Gut. 2006 Aug;55(8):1065-7. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk